Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 0 | 6,254 | 0 | 0 | 1,037 |
Gross Profit | N/A | 6,254 | N/A | N/A | 1,037 |
Operating Expenses | 62,889 | 25,129 | 23,666 | 27,258 | 40,679 |
Operating Income | -62,889 | -18,875 | -23,666 | -27,258 | -39,642 |
Other Income | 101 | 72 | 71 | 58 | 224 |
Pre-tax Income | -62,788 | -18,803 | -23,595 | -27,200 | -39,418 |
Net Income Continuous | -60,257 | -18,803 | -23,595 | -27,200 | -39,418 |
Net Income | $-60,257 | $-18,803 | $-23,595 | $-27,200 | $-39,418 |
EPS Basic Total Ops | -16.21 | -4.92 | -6.60 | -8.28 | -13.33 |
EPS Basic Continuous Ops | -16.23 | -4.95 | -6.61 | -8.23 | -13.28 |
EPS Diluted Total Ops | -16.21 | -4.92 | -6.60 | -8.28 | -13.09 |
EPS Diluted Continuous Ops | -16.23 | -4.95 | -6.61 | -8.23 | -13.15 |
EBITDA(a) | $-20,943 | $-18,607 | $-23,389 | $-27,059 | $-39,261 |